Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive with news the company has launched their CBD derma line. Bincovich discusses where it is being made and the first areas of the world it is being rolled out to.
Bincovich also told gave Proactive an update on their Pharma work and how their capital raise is going.
CSE:INNO
Market: CSE
Market Cap: $23.74 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of InnoCan Pharma named herein, including the promotion by the Company of InnoCan Pharma in any Content on the Site, the Company receives from...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
Full interview: InnoCan Pharma signs deal with ADVA Biotechnology to produce...
InnoCann Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive Vancouver with news the company has signed a Letter of Intent with ADVA Bio-Technology for exosome manufacturing and development. Bincovich telling Proactive InnoCan intends to load the produced exosomes with...
2 weeks ago
2 min read
Prev article
2 min read
